Latanoprostene bunod is primarily used in the treatment of glaucoma and ocular hypertension. It works by reducing intraocular pressure, which is crucial in preventing optic nerve damage and preserving vision. The compound is metabolized into latanoprost and butanediol mononitrate, which enhance the outflow of aqueous humor through both the trabecular meshwork and uveoscleral pathways. This dual mechanism of action makes it highly effective for patients who require significant intraocular pressure reduction. It is typically administered as an ophthalmic solution, ensuring targeted delivery and minimizing systemic side effects. Regular use helps in maintaining stable eye pressure, thereby reducing the risk of vision loss associated with these conditions.